Related Experiment Video
Updated: Aug 7, 2026

07:54
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
Published on: March 31, 2021
5.6K
IMPLEMENTING TOOLS TO PROMOTE ADHERENCE TO ANTIRETROVIRAL THERAPY AT FACILITIES IN KENYA
East African Medical Journal
|February 11, 2016
Summary
Implementing a new appointment keeping system and clinic form improved adherence monitoring for patients on anti-retroviral treatment (ART). This intervention empowered providers to identify and support patients, enhancing treatment adherence and appointment keeping.
Area of Science:
- Public Health
- Health Services Research
- HIV/AIDS Management
Background:
- Adherence monitoring for anti-retroviral treatment (ART) is challenged by a lack of effective systems to track patient defaulters.
- An intervention introduced a facility-based appointment keeping system and a revised clinic form to improve ART adherence monitoring.
Purpose of the Study:
- To assess healthcare staff perceptions, motivation, and self-reported practices regarding the implementation of an adherence monitoring intervention.
- To evaluate the use of adherence-based indicators for informing performance improvement decisions.
Main Methods:
- A qualitative explorative study design was used to evaluate a quasi-experimental intervention.
- Data were collected through interviews with 36 clinic staff members across six health facilities in Kenya.
- Analysis followed the Pettigrew and Whipp framework.
Main Results:
- Healthcare providers felt empowered to manage daily workloads and identify patients missing appointments.
- Key factors for successful uptake included monitoring tools, adherence training, and supervisory support.
- Early identification of treatment defaulters enabled targeted patient support to improve appointment keeping.
Conclusions:
- The intervention successfully led to clinic-based changes that enhanced patient appointment keeping and ART adherence.
- The sustainability of observed changes is expected as providers were actively involved in data generation and indicator calculation for decision-making.
Related Concept Videos
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.